-
p-tau Ser356, NUAK Inhibition, and Alzheimer’s Disease
2026-08-24
The reference study links p-tau Ser356 to Braak stage, neurofibrillary tangles, and synaptic regions in Alzheimer’s disease brain tissue. Its ex vivo comparison further shows that NUAK inhibition produces distinct tau and neuronal responses in postnatal mouse versus adult human brain slice cultures, highlighting the importance of model context in therapeutic development.
-
GKT137831 for Nox1/Nox4 Redox Assays
2026-08-24
GKT137831 provides a practical way to separate Nox1/Nox4-driven reactive oxygen species signaling from downstream vascular, fibrotic, and ferroptosis-associated phenotypes. This workflow-focused guide covers dose selection, orthogonal readouts, controls, and troubleshooting for reproducible oxidative stress research.
-
Ferroptosis-Related lncRNAs in Pancreatic Cancer
2026-08-23
The reference study developed a nine-lncRNA ferroptosis-related signature for risk stratification in pancreatic adenocarcinoma and validated it across TCGA and ICGC cohorts. Its findings connect ferroptosis-associated transcriptional patterns with overall survival, immune infiltration, and potential immunotherapy response, while also highlighting the need for prospective and functional validation.
-
Eicosapentaenoic Acid: Applied Research Workflows
2026-08-22
Build reproducible Eicosapentaenoic Acid experiments around two differentiated endpoints: endothelial cell migration inhibition and low-micromolar lipoprotein oxidation control. This guide translates EPA membrane biology into practical assay design, troubleshooting, and carefully bounded comparisons with recent arachidonic acid immunology research.
-
Lipidated Nanophotosensitizer Disables Tumor EVs
2026-08-22
Miao and colleagues developed a palmitic-acid-displayed nanophotosensitizer that tracks tumor extracellular vesicles and generates reactive oxygen species inside both tumor cells and vesicles. The study shows how one light-activated platform can suppress primary tumors while disrupting TEV-mediated communication linked to metastasis, although translation beyond the tested preclinical models remains to be established.
-
Merbromin BA1653 for Reliable Assays
2026-08-21
Learn how Merbromin (SKU BA1653) can support protein-binding fluorescence studies, enzyme inhibition assays, and carefully controlled antimicrobial or antiviral screening workflows. This scenario-based guide emphasizes solvent compatibility, assay controls, interpretation, storage, and practical vendor selection.
-
DHHC9–STRN4 Palmitoylation Drives YAP Metastasis
2026-08-20
The reference study identifies a DHHC9–STRN4 palmitoylation–YAP axis that connects lipid modification to Hippo pathway dysregulation and adenocarcinoma metastasis. Its genetic, proteomic, and pharmacological evidence supports DHHC9 as a potential therapeutic target while also highlighting the need for better inhibitor selectivity and clinical validation.
-
α-Amanitin for Reliable Transcription Assays
2026-08-20
Learn how α-Amanitin (SKU A4548) can improve interpretation of transcription, proliferation, viability, and embryo-development experiments. This scenario-based guide connects mechanism, protocol design, storage, data interpretation, and vendor selection with product specifications and recent chromatin research.
-
CAY10499: A Mechanistic Lipid Assay Framework
2026-08-19
CAY10499, an inhibitor of human hormone sensitive lipase, enables controlled analysis of fatty-acid and endocannabinoid flux. This article distinguishes lipase perturbation from EV-transferred ACLY signaling and provides practical assay logic for metabolic and immunometabolic research.
-
Carvacrol: From Redox Sensing to Translational Strategy
2026-08-19
Carvacrol, also known as 5-isopropyl-2-methylphenol, is more than a natural product with antibacterial and antioxidant associations. This thought-leadership article connects its cell-cycle and apoptosis biology with emerging TRPV1/TRPA1 redox-sensing evidence, offering translational researchers a practical framework for assay design, reagent handling, and go/no-go decisions.
-
TAK-242 (Resatorvid): TLR4 Workflow Guide
2026-08-18
TAK-242 (Resatorvid) enables controlled dissection of LPS-triggered TLR4 signaling, from cytokine assays to tissue factor-positive extracellular vesicle studies. This guide translates its nanomolar activity into practical workflows for inflammation, coagulation, and neuroinflammation research while highlighting controls and troubleshooting strategies.
-
12-O-tetradecanoyl phorbol-13-acetate Workflow
2026-08-18
Build reproducible PKC and ERK/MAPK experiments with TPA using controlled stock preparation, time-resolved phospho-ERK sampling, and orthogonal phenotype readouts. The workflow also shows how TPA can function as a mechanistic pathway control when studying cisplatin resistance, autophagy, and ERK1/2 signaling in ovarian cancer models.
-
Crizotinib hydrochloride in ALK Assays
2026-08-17
Crizotinib hydrochloride brings ALK, c-Met, and ROS1 pathway testing into patient-derived gastric cancer assembloid workflows. This guide explains how to compare organoids with matched tumor–stroma models, quantify signaling suppression, and troubleshoot variability without mistaking general cytotoxicity for target engagement.
-
Abiraterone acetate in 3D Prostate Cancer Models
2026-08-17
Learn how to use Abiraterone acetate as a CYP17 inhibitor in patient-derived prostate cancer spheroids, from solvent preparation through pathway-aware response analysis. The workflow combines translational 3D modeling, androgen receptor activity inhibition, and troubleshooting for variable drug penetration or absent responses.
-
Docosahexaenoic Acid (DHA) Research Workflows
2026-08-16
Build reproducible DHA experiments around membrane biology, oxidative stress reduction, and apoptosis modulation rather than treating DHA as a generic antioxidant. This guide connects practical neuroprotection workflows with a carefully bounded lesson from recent lipid-immunity research.